| 7:00 AM - 8:00 AM | PME or CME Symposium |
| 8:00 AM - 8:30 AM | Break |
| 8:30 AM - 9:00 AM | Keynote - Call To Action: Addressing The Disproportionate Burden & Disparities with COVID-19 Keith C. Ferdinand, MD |
| 9:00 AM - 10:00 AM | Keynote Panel Discussion - Roadblocks & Reflections: Looking for Solutions in a Time of Crisis Moderator: Keith C. Ferdinand, MD Panelists: Alanna A. Morris MD, MSc, FHFSA, FACC, FAHA |
| 10:00 AM | Chair Introduction George L. Bakris, MD |
| 10:00 AM - 11:30 AM | CME Special Symposium New Frontiers in Heart Failure Management
|
| 11:30 AM - 12:00 PM | Company Spotlight Break |
| 12:00 PM - 1:00 PM | PME Symposium Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc and Lilly USA, LLC. |
| 1:00 PM - 1:30 PM | Break |
| 1:30 PM - 1:50 PM | Evaluating Risk of CKD Progression Joseph A. Vassalotti, MD |
| 1:50 PM - 2:10 PM | Updates in the Prevention and Treatment of CKD Aldo J. Peixoto, MD |
| 2:10 PM - 2:30 PM | Primary Aldosteronism: An Underappreciated Issue in HTN William F. Young, Jr., MD, MSc |
| 2:30 PM - 3:00 PM | DKD/HTN Challenging Cases & Expert Panel Discussion Moderator: George L. Bakris, MD Panel: Aldo J. Peixoto, MD; Ileana L. Piña, MD; Joseph A. Vassalotti, MD; William F. Young, Jr., MD, MSc |
| 3:00 PM - 3:10 PM | Break |
| 3:10 PM - 3:15 PM | Chair Introduction Anne L. Peters, MD |
| 3:15 PM - 3:35 PM | Glycemic Management in Patients with CVD Vanita Aroda, MD |
| 3:35 PM - 3:55 PM | Exercise as "Medicine" in the Treatment of T2DM Jane Reusch, MD |
| 3:55 PM - 4:15 PM | Relationship Between TIR and Diabetes Complications Nicholas B. Argento, MD, FACE |
| 4:15 PM - 4:35 PM | What is the Role of CGM in Prediabetes/Type 2 Diabetes? Viral Shah, MD |
| 4:35 PM - 5:05 PM | Company Spotlight Break |
| 5:05 PM - 5:25 PM | Inpatient Use of CGM Joseph A. Aloi, MD |
| 5:25 PM - 5:45 PM | Use of Insulin Pumps in the Management of T2DM Grazia Aleppo, MD, FACE, FACP |
| 5:45 PM - 6:15 PM | Challenges Cases & Panel Discussions Moderator: Anne L. Peters, MD Panel: Joseph A. Aloi, MD; Grazia Aleppo, MD, FACE, FACP; Nicholas B. Argento, MD, FACE; Vanita Aroda, MD; Robert H. Eckel, MD; Jane Reusch, MD; Viral Shah, MD |
| 6:15 PM | Closing Remarks Anne L. Peters, MD |
| 6:15 PM - 6:45 PM | Break |
| 6:45 PM - 7:45 PM | PME Symposium Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc and Lilly USA, LLC. |
| 7:00 AM - 8:00 AM | PME or CME Symposium |
| 8:00 AM - 8:30 AM | Break |
| 8:30 AM - 8:35 AM | Chair Introduction and Opening Remarks Robert H. Eckel, MD |
| 8:35 AM - 8:55 AM | The Evolving Landscape of Obesity Management - A 2021 Update Louis J. Aronne, MD |
| 8:55 AM - 9:15 AM | Practical Tips to Help Your Patients Succeed In Their Weight Loss Journey Donna H. Ryan, MD |
| 9:15 AM - 10:05 AM | Challenges Cases & Panel Discussions - Practical Approaches to Weight Reduction Moderator: Robert H. Eckel, MD Panel: Louis J. Aronne, MD ; Donna H. Ryan, MD |
| 10:05 AM - 10:35 AM | Company Spotlight Break |
| 10:35 AM - 11:20 AM | Expert Perspectives - Best Approaches to Diets for Cardiometabolic Health Kim A. Williams, Sr., MD; Penny M. Kris-Etherton, PhD; Sarah Hallberg, DO |
| 11:20 AM - 12:05 PM | Challenging Cases & Expert Panel Discussion Moderator: Robert H. Eckel, MD Panel: Penny M. Kris-Etherton, PhD; Sarah Hallberg, DO; Kim A. Williams, Sr., MD |
| 12:05 PM - 12:10 PM | Closing Remarks Robert H. Eckel, MD |
| 12:10 PM - 12:25 PM | Break |
| 12:25 PM - 1:25 PM | CME Symposium Antithrombotic Therapy for Symptomatic PAD: Interpreting the Evidence and Recent Advances Chair: Deepak L. Bhatt, MD, MPH Faculty: Marc P. Bonaca, MD, MPH; Manesh R. Patel, MD Supported by an educational grant from Janssen Scientific Affairs, LLC. and AstraZeneca. |
| 1:25 PM - 1:40 PM | Break |
| 1:40 PM - 1:45 PM | Chair Introduction Christie M. Ballantyne, MD |
| 1:45 PM - 2:15 PM | Risk Prediction: Role of Imaging, Biomarkers, and Genetics Matthew J. Budoff, MD |
| 2:15 PM - 2:35 PM | Update on Inflammation and CVD Brendan M. Everett, MD |
| 2:35 PM - 3:05 PM | Post-MI: When to Start Lipid-lowering Therapy and How Low to Go Pamela B. Morris, MD |
| 3:05 PM - 3:35 PM | Company Spotlight Break |
| 3:35 PM - 4:05 PM | Stroke Prevention in the Cardiometabolic Patient with Atrial Fibrillation |
| 4:05 PM - 4:45 PM | Antithrombotic and Antiplatelet Therapy in the Cardiometabolic Patient Supported by an educational grant from Janssen Scientific Affairs, LLC Deepak L. Bhatt, MD, MPH |
| 4:45 PM - 5:10 PM | Expert Panel Discussion and Q&A Moderator: Christie M. Ballantyne, MD Panel: Deepak L. Bhatt, MD, MPH; Matthew J. Budoff, MD; Robert H. Eckel, MD; Brendan M. Everett, MD; Margo B. Minissian, PhD, ACNP, NEA-BC, FNLA, FAHA; Pamela B. Morris, MD |
| 5:10 PM - 5:15 PM | Closing Remarks Christie M. Ballantyne, MD |
| 5:15 PM - 5:45 PM | Break |
| 5:45 PM - 6:45 PM | PME or CME Symposium |
| 7:25 AM - 7:30 AM | Introduction and Opening Remarks |
| 7:30 AM - 8:30 AM | Impacts of COVID-19 on Cardiometabolic Risk
|
| 8:30 AM - 9:20 AM | Challenging Cases & Expert Panel Discussion: COVID-19 and Cardiometabolic Diseases Moderator: Robert H. Eckel, MD Panelists: Carl J. Lavie, MD; Margo B. Minissian, PhD, ACNP, NEA-BC, FNLA, FAHA; Ileana L. Piña, MD; Jay H. Shubrook,DO, FACOFP, FAAFP; Clyde W. Yancy, MD, MSc, MACP |
| 9:20 AM - 10:40 AM | Telemedicine in Cardiometabolic Health: The Good, The Bad, and The Ugly
|
| 10:40 AM - 11:10 AM | Interactive Panel Discussion: Optimizing Telemedicine to Meet Immediate and Long-term Demands in the COVID-19 Era Moderator: Robert H. Eckel, MD Panelists: Bartolome Burguera, MD, PhD; Daichi Shimbo, MD; Ahmed M. Soliman, MD |
| 11:10 AM - 11:15 AM | Closing Remarks Robert H. Eckel, MD |
A division of Tarsus Medical owned by Tarsus Group
